Lumbar Sympathetic Blockade in Children with Complex Regional Pain Syndromes A Double Blind Placebo-controlled Crossover Trial

被引:49
|
作者
Meier, Petra M. [1 ]
Zurakowski, David [1 ]
Berde, Charles B. [1 ]
Sethna, Navil F. [1 ]
机构
[1] Harvard Univ, Childrens Hosp, Sch Med, Dept Anesthesiol Perioperat & Pain Med, Boston, MA 02115 USA
关键词
INTRAVENOUS LIDOCAINE; STELLATE GANGLION; SENSORY THRESHOLDS; NEUROPATHIC PAIN; MAINTAINED PAIN; NERVOUS-SYSTEM; INJURY; HYPERALGESIA; DYSTROPHY; CAPSAICIN;
D O I
10.1097/ALN.0b013e3181aaea90
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Background: Sympathetic blockade is used in the management of complex regional pain syndromes in children, but there are no data on the efficacy or mechanism(s) by which it produces pain relief. The purpose of this study is to compare the efficacy of lidocaine administered by lumbar sympathetic to IV route. Methods: Under general anesthesia, children with unilateral lower limb complex regional pain syndromes received catheters along the lumbar sympathetic chain. In a double-blind placebo-controlled crossover design, patients received IV lidocaine and lumbar sympathetic saline or lumbar sympathetic lidocaine and IV saline. Spontaneous and evoked pain ratings and sensory thresholds were assessed before and after these two lidocaine/saline doses and between routes of lumbar sympathetic blockade and IV. Results: Twenty-three patients, ages 10-18 yr, were enrolled. There was evidence for reduction of mean pain intensity of allodynia to brush (mean -1.4, 95% confidence interval [CI] -2.5 to -0.3) and to pinprick temporal summation (mean -1.3, 95% Cl -2.5 to -0.2) with lidocaine treatment via the lumbar sympathetic blockade compared to IV route. Lumbar sympathetic blockade also produced significant reduction in pain intensity compared to pretreatment values of allodynia to brush, pinprick and pinprick temporal summation and verbal pain scores. IV lidocaine did not produce significant changes in spontaneous and evoked pain intensity measurements compared to pretreatment values. There were no carryover effects as assessed by route-by-period interaction. Conclusions: Under the conditions of this study, the results provide some direct evidence that a component of pain may be mediated by abnormal sympathetic efferent activity.
引用
收藏
页码:372 / 380
页数:9
相关论文
共 50 条
  • [41] Secretin in children with autistic disorder: A double-blind, placebo-controlled trial
    Handen, BL
    Hofkosh, D
    JOURNAL OF DEVELOPMENTAL AND PHYSICAL DISABILITIES, 2005, 17 (02) : 95 - 106
  • [42] A placebo-controlled, double-blind, crossover trial of melatonin in the management of sleep disturbances in children with behavioral disorders.
    Hood, EH
    Buttross, S
    Parks, B
    JOURNAL OF INVESTIGATIVE MEDICINE, 1999, 47 (02) : 114A - 114A
  • [43] Randomized Double-Blind Placebo-Controlled Crossover Trial for the Diagnosis of Non-Celiac Gluten Sensitivity in Children
    Francavilla, R.
    Cristofori, F.
    Verzillo, L.
    Gentile, A.
    Castellaneta, S.
    Polloni, C.
    Giorgio, V.
    Verduci, E.
    D'Angelo, E.
    Dellatte, S.
    Indrio, F.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2018, 113 (03): : 421 - 430
  • [44] Double-blind evaluation of lumbar sympathetic blockade in children and adolescents with complex regional pain syndrome type 1: Clinical outcomes and quantitative sensory testing
    Meier, PM
    Berde, CB
    Sethna, NF
    ANESTHESIOLOGY, 1999, 91 (3A) : U399 - U399
  • [45] A randomized, double-blind, placebo-controlled, crossover trial of methylphenidate in children with hyperactivity associated with pervasive developmental disorders
    Posey, DJ
    McDougle, CJ
    Aman, MG
    Arnold, LE
    Scahill, L
    McCracken, JT
    Tierney, E
    Vitiello, B
    Chuang, S
    NEUROPSYCHOPHARMACOLOGY, 2004, 29 : S142 - S143
  • [46] Treatment of chronic constipation with colchicine: Randomized, double-blind, placebo-controlled, crossover trial
    Verne, GN
    Davis, RH
    Robinson, ME
    Gordon, JM
    Eaker, EY
    Sninksy, CA
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2003, 98 (05): : 1112 - 1116
  • [47] Armodafinil for Sarcoidosis-Associated Fatigue: A Double-Blind, Placebo-Controlled, Crossover Trial
    Lower, Elyse E.
    Malhotra, Atul
    Surdulescu, Victoria
    Baughman, Robert P.
    JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2013, 45 (02) : 159 - 169
  • [48] Randomized, double-blind, placebo-controlled crossover trial of Famotidine in patients with functional dyspepsia
    Kato, Mototsugu
    Yoshida, Takeshi
    Hata, Tamotsu
    Ono, Yuji
    Ono, Shouko
    Nakagawa, Manabu
    Nakagawa, Souichi
    Shimizu, Yuichi
    Asaka, Masahiro
    GASTROENTEROLOGY, 2006, 130 (04) : A158 - A158
  • [49] Improvement of erectile function with Prelox: a randomized, double-blind, placebo-controlled, crossover trial
    R Stanislavov
    V Nikolova
    P Rohdewald
    International Journal of Impotence Research, 2008, 20 : 173 - 180
  • [50] Tolcapone in Obsessive Compulsive Disorder: A Randomized Double-Blind Placebo-Controlled Crossover Trial
    Grant, Jon
    Chamberlain, Samuel
    NEUROPSYCHOPHARMACOLOGY, 2021, 46 (SUPPL 1) : 312 - 313